ArticleInternational journal of molecular sciences2017

The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses.

Rossella Talotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.